ALERT!

This site is not optimized for Internet Explorer 8 (or older).

Please upgrade to a newer version of Internet Explorer or use an alternate browser such as Chrome or Firefox.

Coronary Disease

August 10, 2018
The latest instalment in the gender discordance saga, this one proferred by business/management school academics. I am not convinced that the coarse gender comparison takes into account the size discrepancy in coronary arteries and other, well-known to medical practitioners, anatomico-physiological differences of human genders.
August 9, 2018
This is a further report from the extensive dataset of the STICH Trial. This examines the impact of immediate postoperative events (length of time of intubation) on short- and long-term outcomes. If the time  was >36 hours, there was significant correlation with increased mortality, both 30-day and one-year.
July 17, 2018
The use of ultrasonic energy in vessel harvesting for coronary artery bypass provides several advantages over the conventional diathermy during the preparation of the arterial graft, and harmonic shears may be beneficial in being faster, reducing bleeding, and allowing the surgeon to work closely to the vessel.
July 6, 2018
A detailed and somewhat disheartening analysis of stem cell therapy for cardiac failure.
June 15, 2018
Find it here: The 2018 ISMICS Annual Meeting in Vancouver, Canada.
May 23, 2018
Over 1200 patients with stable coronary artery disease and at least one angiographically-significant stenosis were randomized to percutaneous coronary intervention (PCI) plus medical therapy or medical therapy alone for lesions with fractional flow reserve (FFR) <0.8.  FFR-guided PCI was associated with a significantly reduced composite outcome (d
April 24, 2018
The authors report on a randomized, multicenter, open-label, clinical trial involving 500 patients with 1460 saphenous vein grafts (SVG) who were assigned to three groups: (1) ticagrelor + asprin (ASA), (2) ticagrelor alone, or (3) ASA alone.  Neither patients nor physicians were blinded to the allocation.  The primary outcome was SVG patency at one
April 20, 2018
The authors present the 5-year follow-up results of the HYBRID trial, wherein 200 patients with multivessel disease requiring revascularization were randomized to either conventional coronary artery bypass grafting (CABG) or hybrid coronary revascularization (HCR).  Notably, the patients undergoing HCR  had a LIMA to LAD via a minimally invasive appr
April 6, 2018
Patient Care A baby in Taiwan is the third-lightest to have undergone repair of a type A interrupted aortic arch and aortopulmonary window.

Pages